14-23416185-A-T
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 5P and 2B. PM1PM5PP2BP4_Moderate
The NM_000257.4(MYH7):c.4772T>A(p.Leu1591Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1591P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYH7 | NM_000257.4 | c.4772T>A | p.Leu1591Gln | missense_variant | Exon 34 of 40 | ENST00000355349.4 | NP_000248.2 | |
| MYH7 | NM_001407004.1 | c.4772T>A | p.Leu1591Gln | missense_variant | Exon 33 of 39 | NP_001393933.1 | ||
| MHRT | NR_126491.1 | n.446A>T | non_coding_transcript_exon_variant | Exon 3 of 6 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYH7 | ENST00000355349.4 | c.4772T>A | p.Leu1591Gln | missense_variant | Exon 34 of 40 | 1 | NM_000257.4 | ENSP00000347507.3 | ||
| MYH7 | ENST00000713768.1 | c.4772T>A | p.Leu1591Gln | missense_variant | Exon 34 of 41 | ENSP00000519070.1 | ||||
| MYH7 | ENST00000713769.1 | c.4772T>A | p.Leu1591Gln | missense_variant | Exon 33 of 39 | ENSP00000519071.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152088Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251476 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461846Hom.: 0 Cov.: 34 AF XY: 0.0000344 AC XY: 25AN XY: 727220 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74280 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cardiomyopathy Uncertain:3
This missense variant replaces leucine with glutamine at codon 1591 of the MYH7 protein. Computational prediction tools indicate that this variant has a neutral impact on protein structure and function. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in one individual affected with sudden cardiac death and myocarditis (PMID: 25447171). This individual and six relatives diagnosed with arrhythmogenic cardiomyopathy all carried a pathogenic truncation variant in the PKP2 gene that could explain the observed phenotype in this family (PMID: 31156706). This variant has been identified in 10/251476 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
This missense variant replaces leucine with glutamine at codon 1591 of the MYH7 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with sudden cardiac death and myocarditis (PMID 25447171). This individual and six relatives diagnosed with arrhythmogenic cardiomyopathy all carried a pathogenic truncation variant in the PKP2 gene that could explain the observed phenotype in this family (PMID: 31156706). This variant has been identified in 10/251476 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Congenital myopathy with fiber type disproportion;C1834481:Dilated cardiomyopathy 1S;C1842160:Myosin storage myopathy;C1850709:Myopathy, myosin storage, autosomal recessive;C3495498:Hypertrophic cardiomyopathy 1;C4552004:MYH7-related skeletal myopathy Uncertain:1
not provided Uncertain:1
Hypertrophic cardiomyopathy Uncertain:1
This sequence change replaces leucine, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 1591 of the MYH7 protein (p.Leu1591Gln). This variant is present in population databases (rs730880808, gnomAD 0.007%). This missense change has been observed in individual(s) with Laing distal myopathy (PMID: 22918376). ClinVar contains an entry for this variant (Variation ID: 181265). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MYH7 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Cardiovascular phenotype Uncertain:1
The p.L1591Q variant (also known as c.4772T>A), located in coding exon 32 of the MYH7 gene, results from a T to A substitution at nucleotide position 4772. The leucine at codon 1591 is replaced by glutamine, an amino acid with dissimilar properties. This alteration has been reported in at least two cases of sudden cardiac death and has been seen in at least one hypertrophic cardiomyopathy (HCM) cohort (Campuzano O et al. Front Genet, 2019 May; Yamaguchi-Kabata Y et al. J Hum Genet, 2018 Feb;63:213-230; 10:450; Homburger JR et al. Proc Natl Acad Sci U S A, 2016 06;113:6701-6; Campuzano O et al. J. Am. Coll. Cardiol., 2015 Dec;66:2913-2914; Campuzano O et al. Forensic Sci Int, 2014 12;245:30-7). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at